Primary angioplasty procedure in a person who had<unk>  after heart transplantation. Statins Prevention of<unk>  progression is important as once developed,<unk>  existing treatments are often ineffective. Commencing the statins pravastatin and simvastatin early after transplantation reduces the incidence and severity of<unk> . Vitamins When combined with immunosuppressants, the progression of<unk>  could possibly be slowed by vitamins C and E. Aspirin Since the role of aspirin is already established in coronary artery disease in those who have not had a heart transplant, it is usually given after heart transplantation too. Antiproliferative agents On detection of<unk> , medications including mTOR inhibitors sirolimus and everolimus have been shown to slow disease progression. Other treatment options Clinically significant<unk>  may require percutaneous coronary interventions for focal disease, but the likelihood of restenosis is high. A repeat heart transplantation may be considered.
Cardiac allograft vasculopathy
Graft-versus-host disease
Chronic allograft nephropathy
Transplant rejection
Cardiac amyloidosis
Extrapulmonary tuberculosis
Vasculogenic mimicry
Transplant glomerulopathy